Relative cost of etanercept versus infliximab in the treatment of rheumatoid arthritis.

被引：0
|
作者：
Sweis, BP
Ellman, CJ
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Jordan, Amman, Jordan
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [41] Etanercept for the treatment of rheumatoid arthritis
    Zhao, Sizheng
    Mysler, Eduardo
    Moots, Robert J.
    IMMUNOTHERAPY, 2018, 10 (06) : 433 - 445
  • [42] Etanercept for the treatment of rheumatoid arthritis
    Lethaby, Anne
    Lopez-Olivo, Maria Angeles
    Maxwell, Lara
    Burls, Amanda
    Tugwell, Peter
    Wells, George A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (05):
  • [43] Treatment of rheumatoid arthritis with etanercept
    Genovese, MC
    Kremer, JM
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (02) : 311 - +
  • [44] Etanercept in the treatment of rheumatoid arthritis
    Hunt, Laura
    Emery, Paul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (10) : 1441 - 1450
  • [45] A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
    Chen, Y-F
    Jobanputra, P.
    Barton, P.
    Jowett, S.
    Bryan, S.
    Clark, W.
    Fry-Smith, A.
    Burls, A.
    HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (42) : 1 - +
  • [46] Impact of treatment with infliximab on anticyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis.
    Mubashir, E
    Ahmed, MM
    Wolf, RE
    Hayat, S
    Hall, VC
    Shi, R
    Berney, SM
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S284 - S284
  • [47] A threshold cost-effectiveness comparison of infliximab and etanercept in adults with rheumatoid arthritis in the UK.
    Bansback, N
    Brennan, A
    Conway, P
    Reynolds, AV
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S582 - S582
  • [48] Combination treatment with infliximab and methotrexate or leflunomide in active rheumatoid arthritis. Safety and efficacy
    Athanassiou, P
    Kostoglou-Athanassiou, I
    Koutsogeorgopoulou, L
    Galanaki, C
    Kordalis, A
    Konstantopoulou, R
    Sarlanis, T
    Vezyroglou, G
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 464 - 464
  • [49] Cost-effectiveness of anakinra plus methotrexate versus methotrexate alone for the treatment of rheumatoid arthritis.
    Guh, DP
    Marra, CA
    Woolcott, JC
    Gignac, M
    Esdaile, JM
    Clarke, A
    Anis, AH
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S264 - S264
  • [50] Comparison of the cost-efficacy of biologics in the treatment of rheumatoid arthritis.
    Chiou, CF
    Wanke, LA
    Reyes, C
    Malone, DC
    Ortmeier, BG
    Ofman, JJ
    Weisman, M
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S263 - S263
12345